Atrial fibrillation and left atrial size and function: a Mendelian randomization study

Yordi J van de Vegte1, Joylene E Siland1, Michiel Rienstra1

  • 1Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.

Scientific Reports
|April 20, 2021
PubMed

Insights

Atrial fibrillation (AF) may cause enlarged left atria (LA) and reduced LA function. Genetic analysis suggests AF increases LA size and decreases ejection fraction, with a specific gene variant playing a key role.

Area of Science:

  • Cardiology
  • Genetics
  • Biomedical Imaging

Background:

  • Enlarged left atria (LA) are common in atrial fibrillation (AF) patients.
  • The causal relationship between AF and LA size/function remains debated.
  • Prior studies suggest a bidirectional relationship between AF and LA remodeling.

Purpose of the Study:

  • To investigate the causal association between atrial fibrillation (AF) and left atrial (LA) size and function.
  • To determine if genetic predisposition to AF influences LA dimensions and contractility.
  • To identify genetic variants contributing to the AF-LA relationship.

Main Methods:

  • Utilized UK Biobank data with cardiovascular magnetic resonance imaging.
  • Measured LA maximal volume, minimal volume, stroke volume, and ejection fraction, indexed to body surface area (BSA).
  • Performed two-sample Mendelian randomization analyses using 84 AF-associated genetic variants in individuals without prevalent AF.

Main Results:

  • Genetically predicted AF showed a causal effect on BSA-indexed LA maximal volume, LA minimal volume, and LA ejection fraction.
  • No significant causal association was found between AF and LA stroke volume.
  • Exclusion of rs67249485 (near PITX2) attenuated the observed causal associations, highlighting its role.

Conclusions:

  • Atrial fibrillation causally increases left atrial size.
  • Atrial fibrillation causally decreases left atrial ejection fraction.
  • The rs67249485 variant near the PITX2 gene is a significant contributor to the AF-associated changes in LA size and function.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
122
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
153
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
69